Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

The Role of EMT in Pancreatic Cancer Progression.

Wu Q, Miele L, Sarkar FH, Wang Z.

Pancreat Disord Ther. 2012 Sep 29;2(3). pii: e121. No abstract available.

2.

SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.

Nishioka R, Itoh S, Gui T, Gai Z, Oikawa K, Kawai M, Tani M, Yamaue H, Muragaki Y.

Exp Mol Pathol. 2010 Oct;89(2):149-57. doi: 10.1016/j.yexmp.2010.05.008. Epub 2010 Jun 1.

PMID:
20576520
3.

The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.

Beuran M, Negoi I, Paun S, Ion AD, Bleotu C, Negoi RI, Hostiuc S.

Pancreatology. 2015 May-Jun;15(3):217-25. doi: 10.1016/j.pan.2015.02.011. Epub 2015 Mar 7. Review.

PMID:
25794655
4.
5.

Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner.

Lei J, Ma J, Ma Q, Li X, Liu H, Xu Q, Duan W, Sun Q, Xu J, Wu Z, Wu E.

Mol Cancer. 2013 Jun 20;12:66. doi: 10.1186/1476-4598-12-66.

6.

M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.

Liu CY, Xu JY, Shi XY, Huang W, Ruan TY, Xie P, Ding JL.

Lab Invest. 2013 Jul;93(7):844-54. doi: 10.1038/labinvest.2013.69. Epub 2013 Jun 10.

7.

Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression.

Krantz SB, Shields MA, Dangi-Garimella S, Munshi HG, Bentrem DJ.

J Surg Res. 2012 Mar;173(1):105-12. doi: 10.1016/j.jss.2011.09.020. Epub 2011 Oct 8. Review.

8.

Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.

Wu YS, Chung I, Wong WF, Masamune A, Sim MS, Looi CY.

Biochim Biophys Acta. 2017 Feb;1861(2):296-306. doi: 10.1016/j.bbagen.2016.10.006. Epub 2016 Oct 14.

PMID:
27750041
9.

Regulators of epithelial mesenchymal transition in pancreatic cancer.

Hamada S, Satoh K, Masamune A, Shimosegawa T.

Front Physiol. 2012 Jul 10;3:254. doi: 10.3389/fphys.2012.00254. eCollection 2012.

10.

Contextual regulation of pancreatic cancer stem cell phenotype and radioresistance by pancreatic stellate cells.

Al-Assar O, Demiciorglu F, Lunardi S, Gaspar-Carvalho MM, McKenna WG, Muschel RM, Brunner TB.

Radiother Oncol. 2014 May;111(2):243-51. doi: 10.1016/j.radonc.2014.03.014. Epub 2014 Apr 26.

PMID:
24780634
11.
12.

Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.

Nagathihalli NS, Merchant NB.

Front Biosci (Landmark Ed). 2012 Jun 1;17:2059-69. Review.

PMID:
22652764
13.

MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell.

Lu Y, Lu J, Li X, Zhu H, Fan X, Zhu S, Wang Y, Guo Q, Wang L, Huang Y, Zhu M, Wang Z.

BMC Cancer. 2014 Feb 12;14:85. doi: 10.1186/1471-2407-14-85.

14.

Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.

Zhang Y, Wei J, Wang H, Xue X, An Y, Tang D, Yuan Z, Wang F, Wu J, Zhang J, Miao Y.

Oncol Rep. 2012 May;27(5):1599-605. doi: 10.3892/or.2012.1681. Epub 2012 Feb 7.

PMID:
22322379
15.

Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?

Jiang JH, Liu C, Cheng H, Lu Y, Qin Y, Xu YF, Xu J, Long J, Liu L, Ni QX, Yu XJ.

Biochim Biophys Acta. 2015 Jan;1855(1):43-9. doi: 10.1016/j.bbcan.2014.11.004. Epub 2014 Nov 26. Review.

PMID:
25432020
16.

Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase.

Grosse-Steffen T, Giese T, Giese N, Longerich T, Schirmacher P, Hänsch GM, Gaida MM.

Clin Dev Immunol. 2012;2012:720768. doi: 10.1155/2012/720768. Epub 2012 Nov 20.

17.

Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.

Kohler I, Bronsert P, Timme S, Werner M, Brabletz T, Hopt UT, Schilling O, Bausch D, Keck T, Wellner UF.

J Gastroenterol Hepatol. 2015 Mar;30 Suppl 1:78-84. doi: 10.1111/jgh.12752.

PMID:
25827809
18.

The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer.

Wu Y, Sato F, Yamada T, Bhawal UK, Kawamoto T, Fujimoto K, Noshiro M, Seino H, Morohashi S, Hakamada K, Abiko Y, Kato Y, Kijima H.

Int J Oncol. 2012 Oct;41(4):1337-46. doi: 10.3892/ijo.2012.1559. Epub 2012 Jul 18.

PMID:
22825629
19.

Lipocalin-2 is associated with a good prognosis and reversing epithelial-to-mesenchymal transition in pancreatic cancer.

Xu B, Jin DY, Lou WH, Wang DS.

World J Surg. 2013 Aug;37(8):1892-900. doi: 10.1007/s00268-013-2009-6.

PMID:
23539193
20.

Supplemental Content

Support Center